Abstract
We would like to thank Dr. Kawada for the comments (1) on our paper (2). First, we agree that the use of biomarkers is beneficial for early detection of heart failure and prevention of subsequent other cardiovascular diseases. Second, we agree with the need for careful monitoring of the incidence of cardiovascular diseases other than heart failure, as heart failure is the second most common initial presentation of cardiovascular disease in patients with type 2 diabetes after peripheral arterial disease …
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
